Influenza--recent developments in prophylaxis and treatment.
D000119:Acetylmuramyl-Alanyl-Isoglutamine / Q000031:analogs & derivatives / Q000627:therapeutic use; D000284:Administration, Oral; D000336:Aerosols; D000547:Amantadine / Q000008:administration & dosage / Q000627:therapeutic use; D006801:Humans; D007251:Influenza, Human / Q000188:drug therapy / Q000517:prevention & control* / Q000628:therapy; D007370:Interferon Type I / Q000627:therapeutic use; D010714:Phosphatidylethanolamines / Q000627:therapeutic use; D012254:Ribavirin / Q000627:therapeutic use; D012299:Rimantadine / Q000008:administration & dosage / Q000627:therapeutic use
D000336:Aerosols; D007370:Interferon Type I; D010714:Phosphatidylethanolamines; D012299:Rimantadine; C037144:mifamurtide; D012254:Ribavirin; D000119:Acetylmuramyl-Alanyl-Isoglutamine; D000547:Amantadine